Compare NAT & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NAT | PRCT |
|---|---|---|
| Founded | 1995 | 2009 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 1997 | 2021 |
| Metric | NAT | PRCT |
|---|---|---|
| Price | $5.56 | $20.87 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $4.00 | ★ $35.44 |
| AVG Volume (30 Days) | ★ 3.5M | 1.4M |
| Earning Date | 05-28-2026 | 04-29-2026 |
| Dividend Yield | ★ 8.50% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $308,054,000.00 |
| Revenue This Year | $77.72 | $31.34 |
| Revenue Next Year | N/A | $24.52 |
| P/E Ratio | $525.49 | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $2.60 | $19.35 |
| 52 Week High | $6.34 | $62.17 |
| Indicator | NAT | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 55.24 | 31.35 |
| Support Level | $5.39 | $19.35 |
| Resistance Level | $6.30 | $29.27 |
| Average True Range (ATR) | 0.20 | 1.70 |
| MACD | 0.05 | -0.79 |
| Stochastic Oscillator | 81.10 | 4.85 |
Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.